Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19

The key events that shaped the Medtech Insight Top 100 by sales in 2019

2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.

Top 100

The latest Medtech Insight sales ranking of the top 100 publicly-traded medtech manufacturers is COVID-19-affected for a relatively sizeable proportion of companies ̶ those whose reporting periods closed during 2020. The effect of the pandemic on their sales was often significant, and gave a foretaste of what the rest of the industry will experience when filing calendar year 2020 accounts.

The first implications of the pandemic became apparent for health care provider systems in countries beyond China at the end...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Surgical Procedures

More from Surgery